ALTO vs NBIX · P/E 13, rev $470.4M vs P/E 45, rev $1.77B
Alto Ingredients Inc (ALTO) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Alto Ingredients Inc (ALTO) is a specialty chemicals company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALTO revenue for 2026-06-30 was $470.4M. Net income was $16.0M. ALTO currently screens at market cap $383.6M and trailing P/E 13.4.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ALTO currently screens at market cap $383.6M and trailing P/E 13.4. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ALTO and NBIX stock pages for the full models.
Not investment advice.